Celanese (CE)
(Delayed Data from NYSE)
$136.90 USD
+0.77 (0.57%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $136.96 +0.06 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Celanese Corporation [CE]
Reports for Purchase
Showing records 61 - 80 ( 474 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
2023 Themes, 4Q22 Preview - Trough Is Likely In, but 2023 Is Still a Very Tough Year
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q22 Follow-Up - 4Q May Be Trough, but Recovery Could Be Slow
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q22 First Look - Bull Case Gets More Complicated; 4Q Guide and M&M Below Expectations
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 3Q22 Preview - Estimates Could Sink to Trough Levels by Year-End
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
M&M EBITDA Flat Q/Q in 2Q May Not Be as Bad as Feared; Still Light vs. Target
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q22 Follow-Up - Guidance May Be Ambitious, in Our View
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department